Edwards Lifesciences (EW) Other Non-Current Assets (2016 - 2025)
Edwards Lifesciences (EW) has 17 years of Other Non-Current Assets data on record, last reported at $12.4 million in Q1 2025.
- For Q1 2025, Other Non-Current Assets fell 98.38% year-over-year to $12.4 million; the TTM value through Mar 2025 reached $12.4 million, down 98.38%, while the annual FY2024 figure was $721.6 million, 55.79% up from the prior year.
- Other Non-Current Assets reached $12.4 million in Q1 2025 per EW's latest filing, down from $721.6 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $767.6 million in Q1 2024 and bottomed at $12.4 million in Q1 2025.
- Average Other Non-Current Assets over 5 years is $304.9 million, with a median of $293.6 million recorded in 2023.
- Peak YoY movement for Other Non-Current Assets: soared 169.95% in 2022, then tumbled 98.38% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $110.8 million in 2021, then soared by 169.95% to $299.1 million in 2022, then soared by 54.86% to $463.2 million in 2023, then skyrocketed by 55.79% to $721.6 million in 2024, then tumbled by 98.28% to $12.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $12.4 million in Q1 2025, $721.6 million in Q4 2024, and $767.6 million in Q1 2024.